TIEG1 Inhibitors
The chemical class of TIEG1 Inhibitors encompasses compounds known to influence pathways and processes regulating the expression and activity of TIEG1. This includes glucocorticoids like Dexamethasone, JNK inhibitors such as SP600125, and PI3K/AKT inhibitors like LY294002, which affect signaling pathways potentially linked to TIEG1.
HDAC inhibitors like Vorinostat, TGF-beta signaling inhibitors such as SB431542, mTOR inhibitors like Rapamycin, and MEK inhibitors such as U0126 are included for their potential to modulate pathways associated with TIEG1. Wnt pathway inhibitors, GSK-3 inhibitors like Lithium Chloride, STAT3 inhibitors such as Stattic, NF-kappaB inhibitors like BAY 11-7082, and SMAD inhibitors also play roles in signaling pathways that could impact TIEG1 expression and function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
A glucocorticoid that can modulate inflammatory responses, potentially downregulating TIEG1. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of the JNK signaling pathway, which might indirectly affect TIEG1 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K/AKT pathway inhibitor that can affect various cellular signaling pathways, including those associated with TIEG1. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
An HDAC inhibitor that can alter gene expression patterns, potentially leading to the downregulation of TIEG1. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
An inhibitor of TGF-beta signaling, which might indirectly affect TIEG1. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor affecting cell proliferation and survival pathways, potentially influencing TIEG1 activity. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $36.00 $117.00 $525.00 | 26 | |
A Wnt signaling pathway inhibitor, potentially reducing TIEG1 activity. | ||||||
Stat3 inhibitor V, stattic | 19983-44-9 | sc-202818 sc-202818A sc-202818B sc-202818C sc-202818D sc-202818E sc-202818F | 25 mg 100 mg 250 mg 500 mg 1 g 2.5 g 5 g | $130.00 $196.00 $274.00 $512.00 $731.00 $1408.00 $2091.00 | 114 | |
Inhibits STAT3 signaling, potentially reducing TIEG1-mediated pathways. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
An NF-kappaB inhibitor, potentially reducing the activity of transcription factors like TIEG1. | ||||||